Skip to main content

Table 2 Percutaneous coronary intervention procedure and angiographic findings

From: Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

Variables

Group A

Control C1

p Value

Control C2

p Value

p Value

  

(A vs C1)

 

(C1vs C2)

(A vs C2)

Lesion characteristics

 Multivessel PCI

13 (43.3%)

9 (30.0%)

0.421

25 (32.1%)

1.000

0.381

 Target vessel

  Left main disease

0 (0.0%)

1 (3.3%)

1.000

5 (6.4%)

0.875

0.378

  Left anterior descending artery

18 (60.0%)

19 (63.3%)

1.000

47 (60.3%)

0.941

1.000

  Left circumflex artery

11 (36.7%)

11 (36.7%)

1.000

31 (49.7%)

0.941

0.941

  Right coronary artery

11 (36.7%)

11 (36.7%)

1.000

20 (25.6%)

0.370

0.370

 IVUS guidance

9 (31.0%)

4 (13.3%)

0.184

21 (26.9%)

0.213

0.858

 Type B2/C lesion

36 (73.5%)

35 (79.5%)

0.657

90 (81.8%)

0.922

0.323

 Restenotic lesion

2 (2.3%)

1 (4.3%)

1.000

0 (0.0%)

0.634

0.161

 Angiographic thrombus

13 (43.3%)

11 (36.7%)

0.792

30 (38.5%)

1.000

0.807

Procedure characteristics

 Stents per target lesion (n)

1.20 ± 0.41

1.09 ± 0.29

0.124

1.05 ± 0.23

0.460

0.009

 Stent type

  Drug eluting balloon

1

0

 

0

  

  Bare metal stent

0

1

 

0

  

  Drug-eluting stent

53

47

 

117

  

 Stent size

2.70 ± 0.47

2.79 ± 0.46

0.651

2.84 ± 0.45

0.409

0.737

 Stent length

23.7 ± 8.7

21.8 ± 5.5

0.548

23.0 ± 8.7

0.613

0.838

 Duration of loading time to the procedure

34.0 ± 18.6

29.9 ± 18.3

0.480

29.4 ± 16.1

0.917

0.270

 Emergency PCI

1

1

 

0

  
  1. PCI percutaneous coronary intervention, IVUS intravascular ultrasound